While retatrutide has generally been well-tolerated, clinical trials have also revealed a dose-dependent pattern with GI side effects
The medication has a triple action on GLP-1, GIP, and glucagon receptors, making it more effective for blood sugar control and weight loss than current medications such as semaglutide, tirzepatide, dulaglutide, and liraglutide
Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota
As with all emerging therapies, a thorough medical history and individualised risk assessment by a qualified clinician would be essential before any future prescribing
Patients should not discontinue treatment without medical guidance
This evidence-based approach to therapies can seem frustrating and bureaucratic its true there may be room for improvement